期刊
EXPERT REVIEW OF NEUROTHERAPEUTICS
卷 14, 期 5, 页码 493-502出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737175.2014.906304
关键词
comorbidity; premenstrual syndrome; triptans; affective disorders; non-steroidal anti-inflammatory drugs; menstrual migraine; estrogens
Menstrual migraine (MM) has a prevalence in the general population of approximately 7%, although it seems to be much higher within the population of females with migraine. Episodes of MM have been reported to be longer, more intense, more disabling, less responsive to acute therapy and more prone to recurrence than those of other types of migraine. MM is demonstrated to have a bi-directional link to affective illnesses such as premenstrual dysphoric disorder and depression. There is clinical and pathophysiological evidence suggesting that the relationship between MM and affective disorders could be linked to ovarian hormones. The aim of this review is to analyze treatment strategies in patients with co-existent MM and affective disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据